NCT04708106View on ClinicalTrials.gov

Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 7, 2021

Conditions
Electronic Cigarette Use
Interventions
OTHER

RELX ENDS Tobacco Flavor

Ad libitum use of the RELX ENDS Tobacco Flavor product

OTHER

RELX ENDS Menthol Flavor

Ad libitum use of the RELX ENDS Menthol product

OTHER

RELX ENDS Tobacco and Menthol Flavors

Ad libitum use of the RELX ENDS Tobacco and Menthol Flavor products

Trial Locations (5)

37920

AMR - Knoxville, Knoxville

40509

AMR - Lexington, Lexington

65802

QPS, Springfield

72712

Pillar Clinical Research, Bentonville

89119

AMR - Las Vegas, Las Vegas

All Listed Sponsors
lead

Cheerain HK Limited

INDUSTRY

NCT04708106 - Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System | Biotech Hunter | Biotech Hunter